{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:46:35Z","timestamp":1790876795597,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1124\/jpet.105.083386","type":"journal-article","created":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T22:51:51Z","timestamp":1116370311000},"page":"1090-1100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Stilbazulenyl Nitrone, a Second-Generation Azulenyl Nitrone Antioxidant, Confers Enduring Neuroprotection in Experimental Focal Cerebral Ischemia in the Rat: Neurobehavior, Histopathology, and Pharmacokinetics"],"prefix":"10.1016","volume":"313","author":[{"given":"James J.","family":"Ley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Vigdorchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Belayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Busto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Khoutorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron D.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.083386_bib1","doi-asserted-by":"crossref","unstructured":"Becker DA (1996) Highly sensitive colorimetric detection and facile isolation of diamagnetic free radical adducts of novel chromotropic nitrone spin trapping agents readily derived from guaiazulene. J Am Chem Soc 118: 905\u2013906.","DOI":"10.1021\/ja952895z"},{"key":"10.1124\/jpet.105.083386_bib2","doi-asserted-by":"crossref","unstructured":"Becker DA (1998) Aspects of the chemistry and biology of azulenyl nitrones, a newly synthesized class of spin-trapping agents, in Organic Synthesis: Theory and Applications, vol 4, pp 155\u2013177, JAI Press Inc., Greenwich, CT.","DOI":"10.1002\/chin.199851327"},{"key":"10.1124\/jpet.105.083386_bib3","doi-asserted-by":"crossref","unstructured":"Becker DA (1999) Diagnostic and therapeutic applications of azulenyl nitrone spin traps. Cell Mol Life Sci 56: 626\u2013633.","DOI":"10.1007\/s000180050457"},{"key":"10.1124\/jpet.105.083386_bib4","doi-asserted-by":"crossref","unstructured":"Becker DA, Ley JJ, Echegoyen L, and Alvarado R (2002) Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants. J Am Chem Soc 124: 4678\u20134684.","DOI":"10.1021\/ja011507s"},{"key":"10.1124\/jpet.105.083386_bib5","doi-asserted-by":"crossref","unstructured":"Becker DA, Natero R, Echegoyen L, and Lawson RC (1998) Redox behaviour of azulenyl nitrones: fully reversible one electron oxidation by cyclic voltammetry at potentials in the range of biological antioxidants. J Chem Soc Perkin Trans 2 6: 1289\u20131291.","DOI":"10.1039\/a708702k"},{"key":"10.1124\/jpet.105.083386_bib6","doi-asserted-by":"crossref","unstructured":"Belayev L, Alonso OF, Busto R, Zhao W, and Ginsberg MD (1996) Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27: 1616\u20131622.","DOI":"10.1161\/01.STR.27.9.1616"},{"key":"10.1124\/jpet.105.083386_bib7","doi-asserted-by":"crossref","unstructured":"Belayev L, Becker DA, Alonso OF, Liu Y, Busto R, Ley JJ, and Ginsberg MD (2002) Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats. J Neurosurg 96: 1077\u20131083.","DOI":"10.3171\/jns.2002.96.6.1077"},{"key":"10.1124\/jpet.105.083386_bib8","doi-asserted-by":"crossref","unstructured":"Belayev L, Liu Y, Zhao W, Busto R, and Ginsberg MD (2001) Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 32: 553\u2013560.","DOI":"10.1161\/01.STR.32.2.553"},{"key":"10.1124\/jpet.105.083386_bib9","doi-asserted-by":"crossref","unstructured":"Buettner GR (1993) The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol and ascorbate. Arch Biochem Biophys 300: 535\u2013543.","DOI":"10.1006\/abbi.1993.1074"},{"key":"10.1124\/jpet.105.083386_bib10","unstructured":"Busto R and Ginsberg MD (1998) The influence of altered brain temperature in cerebral ischemia, in Cerebrovascular Disease: Pathophysiology, Diagnosis and Management (Ginsberg MD and Bogousslavsky J eds) pp 287\u2013307, Blackwell Science, Malden, MA."},{"key":"10.1124\/jpet.105.083386_bib11","doi-asserted-by":"crossref","unstructured":"Carnevale NT (1986) Integration of data obtained at fixed intervals. Brain Res Bull 16: 137\u2013142.","DOI":"10.1016\/0361-9230(86)90022-5"},{"key":"10.1124\/jpet.105.083386_bib12","doi-asserted-by":"crossref","unstructured":"Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21: 2\u201314.","DOI":"10.1097\/00004647-200101000-00002"},{"key":"10.1124\/jpet.105.083386_bib13","doi-asserted-by":"crossref","unstructured":"Chen G, Griffin M, Poyer JL, and McCay PB (1990) HPLC procedure for the pharmacokinetic study of the spin-trapping agent, alpha-phenyl-N-tert-butyl nitrone (PBN). Free Radic Biol Med 9: 93\u201398.","DOI":"10.1016\/0891-5849(90)90110-5"},{"key":"10.1124\/jpet.105.083386_bib14","doi-asserted-by":"crossref","unstructured":"Cheng HY, Liu T, Feuerstein G, and Barone FC (1993) Distribution of spin-trapping compounds in rat blood and brain: in vivo microdialysis determination. Free Radic Biol Med 14: 243\u2013250.","DOI":"10.1016\/0891-5849(93)90021-L"},{"key":"10.1124\/jpet.105.083386_bib15","unstructured":"Coon JS, Knudson W, Clodfelter K, Lu B, and Weinstein RS (1991) Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res 51: 897\u2013902."},{"key":"10.1124\/jpet.105.083386_bib16","doi-asserted-by":"crossref","unstructured":"Dehouck MP, Cecchelli R, Richard GA, Renftel M, and Lundquist S (2002) In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions. Brain Res 955: 229\u2013235.","DOI":"10.1016\/S0006-8993(02)03469-8"},{"key":"10.1124\/jpet.105.083386_bib17","doi-asserted-by":"crossref","unstructured":"Dietrich WD, Busto R, Alonso O, Globus MY, and Ginsberg MD (1993) Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab 13: 541\u2013549.","DOI":"10.1038\/jcbfm.1993.71"},{"key":"10.1124\/jpet.105.083386_bib18","doi-asserted-by":"crossref","unstructured":"Du C, Hu R, Csernansky CA, Hsu CY, and Choi DW (1996) Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 16: 195\u2013201.","DOI":"10.1097\/00004647-199603000-00003"},{"key":"10.1124\/jpet.105.083386_bib19","doi-asserted-by":"crossref","unstructured":"Fujioka M, Taoka T, Matsuo Y, Mishima K, Ogoshi K, Kondo Y, Tsuda M, Fujiwara M, Asano T, Sakaki T, et al. (2003) Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration. Ann Neurol 54: 732\u2013747.","DOI":"10.1002\/ana.10751"},{"key":"10.1124\/jpet.105.083386_bib20","doi-asserted-by":"crossref","unstructured":"Ginsberg MD, Becker DA, Busto R, Belayev A, Zhang Y, Khoutorova L, Ley JJ, Zhao W, and Belayev L (2003) Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia. Ann Neurol 54: 330\u2013342.","DOI":"10.1002\/ana.10659"},{"key":"10.1124\/jpet.105.083386_bib21","doi-asserted-by":"crossref","unstructured":"Hensley K, Carney JM, Stewart CA, Tabatabaie T, Pye Q, and Floyd RA (1997) Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies. Int Rev Neurobiol 40: 299\u2013317.","DOI":"10.1016\/S0074-7742(08)60725-4"},{"key":"10.1124\/jpet.105.083386_bib22","doi-asserted-by":"crossref","unstructured":"Huh PW, Belayev L, Zhao W, Koch S, Busto R, and Ginsberg MD (2000) Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia. J Neurosurg 92: 91\u201399.","DOI":"10.3171\/jns.2000.92.1.0091"},{"key":"10.1124\/jpet.105.083386_bib23","doi-asserted-by":"crossref","unstructured":"Klivenyi P, Matthews RT, Wermer M, Yang L, MacGarvey U, Becker DA, Natero R, and Beal MF (1998) Azulenyl nitrone spin traps protect against MPTP neurotoxicity. Exp Neurol 152: 163\u2013166.","DOI":"10.1006\/exnr.1998.6824"},{"key":"10.1124\/jpet.105.083386_bib24","doi-asserted-by":"crossref","unstructured":"Kuroda S, Tsuchidate R, Smith ML, Maples KR, and Siesjo BK (1999) Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 19: 778\u2013787.","DOI":"10.1097\/00004647-199907000-00008"},{"key":"10.1124\/jpet.105.083386_bib25","doi-asserted-by":"crossref","unstructured":"Lame ME, Kalgutkar AS, and LaFontaine M (2004) Intravenous pharmacokinetics and metabolism of the reactive oxygen scavenger alpha-phenyl-N-tert-butyl nitrone (PBN) in the cynomolgus monkey. Drug Metab Drug Interact 20: 11\u201324.","DOI":"10.1515\/DMDI.2004.20.1-2.11"},{"key":"10.1124\/jpet.105.083386_bib26","doi-asserted-by":"crossref","unstructured":"Lees KR, Barer D, Ford GA, Hacke W, Kostulas V, Sharma AK, and Odergren T (2003) Tolerability of NXY-059 at higher target concentrations in patients with acute stroke. Stroke 34: 482\u2013487.","DOI":"10.1161\/01.STR.0000053032.14223.81"},{"key":"10.1124\/jpet.105.083386_bib27","doi-asserted-by":"crossref","unstructured":"Lefer DJ and Granger DN (2000) Oxidative stress and cardiac disease. Am J Med 109: 315\u2013323.","DOI":"10.1016\/S0002-9343(00)00467-8"},{"key":"10.1124\/jpet.105.083386_bib28","doi-asserted-by":"crossref","unstructured":"Liu KJ, Kotake Y, Lee M, Miyake M, Sugden K, Yu Z, and Swartz HM (1999) High-performance liquid chromatography study of the pharmacokinetics of various spin traps for application to in vivo spin trapping. Free Radic Biol Med 27: 82\u201389.","DOI":"10.1016\/S0891-5849(99)00042-8"},{"key":"10.1124\/jpet.105.083386_bib29","doi-asserted-by":"crossref","unstructured":"Marklund N, Lewander T, Clausen F, and Hillered L (2001) Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats. J Cereb Blood Flow Metab 21: 1259\u20131267.","DOI":"10.1097\/00004647-200111000-00002"},{"key":"10.1124\/jpet.105.083386_bib30","doi-asserted-by":"crossref","unstructured":"Mojumdar SC, Becker DA, DiLabio GA, Ley JJ, Barclay LR, and Ingold KU (2004) Kinetic studies on stilbazulenyl-bis-nitrone (STAZN), a nonphenolic chain-breaking antioxidant in solution, micelles and lipid membranes. J Org Chem 69: 2929\u20132936.","DOI":"10.1021\/jo030390i"},{"key":"10.1124\/jpet.105.083386_bib31","doi-asserted-by":"crossref","unstructured":"Nath KA and Norby SM (2000) Reactive oxygen species and acute renal failure. Am J Med 109: 665\u2013678.","DOI":"10.1016\/S0002-9343(00)00612-4"},{"key":"10.1124\/jpet.105.083386_bib32","doi-asserted-by":"crossref","unstructured":"Novelli GP, Angiolini P, Tani R, Consales G, and Bordi L (1986) Phenyl-t-butylnitrone is active against traumatic shock in rats. Free Radic Res Commun 1: 321\u2013327.","DOI":"10.3109\/10715768609080971"},{"key":"10.1124\/jpet.105.083386_bib33","doi-asserted-by":"crossref","unstructured":"Reinke LA, Moore DR, Sang H, Janzen EG, and Kotake Y (2000) Aromatic hydroxylation in PBN spin trapping by hydroxyl radicals and cytochrome P-450. Free Radic Biol Med 28: 345\u2013350.","DOI":"10.1016\/S0891-5849(99)00248-8"},{"key":"10.1124\/jpet.105.083386_bib34","doi-asserted-by":"crossref","unstructured":"Schoenberg MH and Beger HG (1993) Reperfusion injury after intestinal ischemia. Crit Care Med 21: 1376\u20131386.","DOI":"10.1097\/00003246-199309000-00023"},{"key":"10.1124\/jpet.105.083386_bib35","doi-asserted-by":"crossref","unstructured":"Strickley RG (2004) Solubilizing excipients in oral and injectable formulations. Pharm Res 21: 201\u2013230.","DOI":"10.1023\/B:PHAM.0000016235.32639.23"},{"key":"10.1124\/jpet.105.083386_bib36","doi-asserted-by":"crossref","unstructured":"Strid S, Borga O, Edenius C, Jostell KG, Odergren T, and Weil A (2002) Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke. Eur J Clin Pharmacol 58: 409\u2013415.","DOI":"10.1007\/s00228-002-0478-x"},{"key":"10.1124\/jpet.105.083386_bib37","doi-asserted-by":"crossref","unstructured":"Sydserff SG, Borelli AR, Green AR, and Cross AJ (2002) Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol 135: 103\u2013112.","DOI":"10.1038\/sj.bjp.0704449"},{"key":"10.1124\/jpet.105.083386_bib38","doi-asserted-by":"crossref","unstructured":"Trudeau-Lame ME, Kalgutkar AS, and LaFontaine M (2003) Pharmacokinetics and metabolism of the reactive oxygen scavenger alpha-phenyl-N-tert-butylnitrone in the male Sprague-Dawley rat. Drug Metab Dispos 31: 147\u2013152.","DOI":"10.1124\/dmd.31.2.147"},{"key":"10.1124\/jpet.105.083386_bib39","doi-asserted-by":"crossref","unstructured":"Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, and Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96: 13496\u201313500.","DOI":"10.1073\/pnas.96.23.13496"},{"key":"10.1124\/jpet.105.083386_bib40","doi-asserted-by":"crossref","unstructured":"Zhao W, Ginsberg MD, Prado R, and Belayev L (1996) Depiction of infarct frequency distribution by computer-assisted image mapping in rat brains with middle cerebral artery occlusion. Comparison of photothrombotic and intraluminal suture models. Stroke 27: 1112\u20131117.","DOI":"10.1161\/01.STR.27.6.1112"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524320117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524320117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.083386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:27:23Z","timestamp":1740000443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524320117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0022356524320117"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.083386","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stilbazulenyl Nitrone, a Second-Generation Azulenyl Nitrone Antioxidant, Confers Enduring Neuroprotection in Experimental Focal Cerebral Ischemia in the Rat: Neurobehavior, Histopathology, and Pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.083386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}